Class Action Complaint in MW Gestion, described as “an institutional asset manager based in France” v. Global Cord Blood Corporation, described as a Cayman Islands-domiciled, Hong Kong-based company that “provides umbilical cord blood storage and ancillary services in the in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People’s Republic of China”; Ting Zheng, Bing Chuen, a.k.a. Albert Chen; Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, Golden Meditech Holdings Limited, of the Cayman Islands; Golden Meditech Stem Cells (BVI) Company Limited, of the British Virgin Islands; GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech Precision Medicine Limited, of Hong Kong; Golden Meditech (BVI) Company Limited, of the British Virgin Islands, and KPMG Huazhen LLP at the U.S. District Court for the Southern District of New York.
Topics
British Virgin Islands Cayman Islands China France FraudKeywords
Albert Chen Bing Chuen Global Cord Blood Corporation GM Precision Medicine Golden Meditech